Dimitrios Ntourakis1, Ricardo Memeo2, Luc Soler2, Jacques Marescaux2, Didier Mutter2, Patrick Pessaux3. 1. IRCAD-IHU, University of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France. dntourakis@hotmail.com. 2. IRCAD-IHU, University of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France. 3. IRCAD-IHU, University of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France. patrick.pessaux@chru-strasbourg.fr.
Abstract
BACKGROUND: Modern chemotherapy achieves the shrinking of colorectal cancer liver metastases (CRLM) to such extent that they may disappear from radiological imaging. Disappearing CRLM rarely represents a complete pathological remission and have an important risk of recurrence. Augmented reality (AR) consists in the fusion of real-time patient images with a computer-generated 3D virtual patient model created from pre-operative medical imaging. The aim of this prospective pilot study is to investigate the potential of AR navigation as a tool to help locate and surgically resect missing CRLM. METHODS: A 3D virtual anatomical model was created from thoracoabdominal CT-scans using customary software (VR RENDER(®), IRCAD). The virtual model was superimposed to the operative field using an Exoscope (VITOM(®), Karl Storz, Tüttlingen, Germany). Virtual and real images were manually registered in real-time using a video mixer, based on external anatomical landmarks with an estimated accuracy of 5 mm. This modality was tested in three patients, with four missing CRLM that had sizes from 12 to 24 mm, undergoing laparotomy after receiving pre-operative oxaliplatin-based chemotherapy. RESULTS: AR display and fine registration was performed within 6 min. AR helped detect all four missing CRLM, and guided their resection. In all cases the planned security margin of 1 cm was clear and resections were confirmed to be R0 by pathology. There was no postoperative major morbidity or mortality. No local recurrence occurred in the follow-up period of 6-22 months. CONCLUSIONS: This initial experience suggests that AR may be a helpful navigation tool for the resection of missing CRLM.
BACKGROUND: Modern chemotherapy achieves the shrinking of colorectal cancer liver metastases (CRLM) to such extent that they may disappear from radiological imaging. Disappearing CRLM rarely represents a complete pathological remission and have an important risk of recurrence. Augmented reality (AR) consists in the fusion of real-time patient images with a computer-generated 3D virtual patient model created from pre-operative medical imaging. The aim of this prospective pilot study is to investigate the potential of AR navigation as a tool to help locate and surgically resect missing CRLM. METHODS: A 3D virtual anatomical model was created from thoracoabdominal CT-scans using customary software (VR RENDER(®), IRCAD). The virtual model was superimposed to the operative field using an Exoscope (VITOM(®), Karl Storz, Tüttlingen, Germany). Virtual and real images were manually registered in real-time using a video mixer, based on external anatomical landmarks with an estimated accuracy of 5 mm. This modality was tested in three patients, with four missing CRLM that had sizes from 12 to 24 mm, undergoing laparotomy after receiving pre-operative oxaliplatin-based chemotherapy. RESULTS:AR display and fine registration was performed within 6 min. AR helped detect all four missing CRLM, and guided their resection. In all cases the planned security margin of 1 cm was clear and resections were confirmed to be R0 by pathology. There was no postoperative major morbidity or mortality. No local recurrence occurred in the follow-up period of 6-22 months. CONCLUSIONS: This initial experience suggests that AR may be a helpful navigation tool for the resection of missing CRLM.
Authors: Bernard Nordlinger; Jean-Nicolas Vauthey; Graeme Poston; Stephane Benoist; Philippe Rougier; Eric Van Cutsem Journal: Clin Colorectal Cancer Date: 2010-10 Impact factor: 4.481
Authors: Rebecca C Auer; Rebekah R White; Nancy E Kemeny; Lawrence H Schwartz; Jinru Shia; Leslie H Blumgart; Ronald P Dematteo; Yuman Fong; William R Jarnagin; Michael I D'Angelica Journal: Cancer Date: 2010-03-15 Impact factor: 6.860
Authors: Csaba Pinter; Andras Lasso; Saleh Choueib; Mark Asselin; Jean-Christophe Fillion-Robin; Jean-Baptiste Vimort; Ken Martin; Matthew A Jolley; Gabor Fichtinger Journal: IEEE Trans Med Robot Bionics Date: 2020-03-26
Authors: Dimitris Gorpas; Dinglong Ma; Julien Bec; Diego R Yankelevich; Laura Marcu Journal: IEEE Trans Med Imaging Date: 2016-02-15 Impact factor: 10.048